Concentra Group Holdings Parent, Inc. schedules five investor conference appearances in Aug-Sept 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Concentra Group Holdings Parent, Inc. (NYSE: CON) will present at five investor conferences from August 11 to September 16, 2026. The schedule includes appearances at Bank of America, RBC, Wells Fargo, Jefferies, and Deutsche Bank events. The company operates 633 occupational health centers and serves approximately 54,000 patients daily as of June 30, 2026.

powered bylight_fuzz_icon
47915309

*this image is generated using AI for illustrative purposes only.

Concentra Group Holdings Parent, Inc. (NYSE: CON), the largest provider of occupational health services in the United States by number of locations, announced today that its executive and senior management team will participate in a series of investor conferences scheduled for August and September 2026. These engagements provide investors with direct access to company leadership to discuss the firm’s strategic direction and operational performance across its nationwide network.

The company’s leadership team is set to appear at five distinct events, spanning virtual and in-person formats across major financial hubs including New York, Boston, and Nashville. Webcast replays of the presentations will be made available on the company’s investor relations website where possible.

Upcoming Investor Conference Schedule

The following table outlines the confirmed conference appearances for Concentra’s management team:

Conference Name Date Location
Bank of America Virtual SMID Cap Conference Aug. 11, 2026 Virtual
RBC Nashville Healthcare Bus Tour Aug. 12, 2026 Nashville, Tenn.
Wells Fargo Healthcare Conference Sept. 9-10, 2026 Boston, Mass.
Jefferies Healthcare Services and Technology Conference Sept. 15, 2026 Nashville, Tenn.
Deutsche Bank Healthcare Summit Sept. 16, 2026 New York, N.Y.

Operational Context

As of June 30, 2026, Concentra operates 633 occupational health centers, 415 onsite health clinics at employer worksites, and Concentra Telemed services. The company supports the care of approximately 54,000 patients each business day on average across 46 states and the District of Columbia. Its workforce includes approximately 13,000 colleagues and affiliated physicians and clinicians who deliver an extensive suite of services, including occupational and consumer health services and other direct-to-employer care.

For additional information regarding the conferences and management presentations, investors may contact Bill Chapman, Vice President of Strategy & Investor Relations, at ir@concentra.com .

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the strategic updates shared at these conferences influence Concentra's valuation relative to other occupational health service providers?

Will management address any specific challenges in maintaining patient volume growth given the current labor market dynamics?

Are there plans to expand the onsite health clinic footprint or integrate new telehealth technologies following these investor engagements?

like19
dislike

Concentra Group Holdings corrects Q2 adjusted EPS to $0.52

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Concentra Group Holdings revised its Q2 adjusted EPS to $0.52, a 40.54% YoY increase, while sales hit $606.030 million, up 10.03% YoY. Both metrics beat analyst estimates.

powered bylight_fuzz_icon
47597234

*this image is generated using AI for illustrative purposes only.

Concentra Group Holdings (NYSE: CON) has issued a correction to its second-quarter financial results, revising its adjusted earnings per share (EPS) upward to $0.52 from the previously reported $0.51. This corrected figure continues to beat the analyst consensus estimate of $0.42, though the margin of outperformance has widened to 23.81 percent from the initially stated 21.43 percent. The revised EPS represents a significant 40.54 percent increase over the $0.37 per share reported in the same period last year, underscoring strong profitability growth despite the minor accounting adjustment.

The company’s top-line performance remains unchanged in the correction. Quarterly sales were reported at $606.030 million, which surpassed the analyst consensus estimate of $591.672 million by 2.43 percent. This marks a 10.03 percent increase in revenue compared to $550.800 million recorded during the same period last year. The consistency in revenue figures suggests that the correction was isolated to the earnings calculation, likely involving adjustments to non-operating items or tax provisions rather than core operational metrics.

Financial Performance Highlights

Metric Reported Value Estimate Beat/Miss YoY Change
Adjusted EPS $0.52 $0.42 +23.81% +40.54%
Quarterly Sales $606.030 million $591.672 million +2.43% +10.03%

What the Numbers Show

The correction reinforces the narrative of robust operational execution at Concentra Group Holdings. While the initial report already indicated a dual beat on both revenue and earnings, the revised EPS of $0.52 further accentuates the divergence between top-line and bottom-line growth. With sales growing by 10.03 percent year-over-year and adjusted EPS surging by 40.54 percent, the data points to significant operational leverage or cost efficiencies driving profit expansion beyond mere volume growth. The ability to exceed estimates on both fronts, even after a positive correction, highlights effective management of financial expectations and underlying business strength during the quarter.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific non-operating items or tax provisions were adjusted to result in the upward EPS revision, and does this suggest a one-time benefit or a sustainable change in accounting practices?

Given the significant divergence between 10% revenue growth and 40% EPS growth, what specific cost-cutting measures or operational leverage drivers is Concentra prioritizing for the remainder of the fiscal year?

How might this strengthened profitability narrative influence analyst consensus estimates for Concentra's full-year earnings and subsequent quarters?

like20
dislike

More News on Concentra Parent